✦ LIBER ✦

A controlled trial of bicalutamide versus flutamide, each in combination with luteinizing hormone-releasing hormone analogue therapy, in patients with advanced prostate cancer

✍ Scribed by Paul Schellhammer; A. Lynn Patterson; Roohollah Sharifi; Michael Sarosdy; Norman Block; Nicholas Vogelzang; Mark Soloway; Julie Jones; Peter Venner; Geert Kolvenbag

Book ID: 119487761
Publisher: Elsevier Science
Year: 1995
Tongue: English
Weight: 936 KB
Volume: 45
Category: Article
ISSN: 0090-4295
DOI: 10.1016/s0090-4295(99)80077-6

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A controlled trial of bicalutamide versu

A controlled trial of bicalutamide versus flutamide, each in combination with luteinizing hormone-releasing hormone analogue therapy, in patients with advanced prostate cancer

✍ E. David Crawford 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 141 KB

A controlled trial of bicalutamide versu

A controlled trial of bicalutamide versus flutamide, each in combination with luteinizing hormone-releasing hormone analogue therapy, in patients with advanced prostate cancer

✍ M. Zerbib; C. Payan 📂 Article 📅 1996 🏛 Elsevier Science 🌐 English ⚖ 237 KB

Maximal androgen blockade for patients w

Maximal androgen blockade for patients with metastatic prostate cancer: outcome of a controlled trial of bicalutamide versus flutamide, each in combination with luteinizing hormone-releasing hormone analogue therapy

✍ Paul Schellhammer; Roohollah Sharifi; Norman Block; Mark Soloway; Peter Venner; 📂 Article 📅 1996 🏛 Elsevier Science 🌐 English ⚖ 840 KB

Bicalutamide and Flutamide, Each in Comb

Bicalutamide and Flutamide, Each in Combination with Luteinizing Hormone-Releasing Hormone Analogs, in Advanced Prostate Cancer: Exploratory Analysis of Impact of Extent of Disease by Bone Scan on Outcome

✍ Mark S. Soloway; Paul F. Schellhammer; Rooholloh Sharifi; Norman L. Block; Peter 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 581 KB

456 A randomized double-blind trial in 8

456 A randomized double-blind trial in 813 previously untreated metastatic prostate cancer (CaP) patients (PTS) comparing a new antiandrogen casodex® (bicalutamide) with eulexin (flutamide) in combination with luteinizing hormone releasing hormone analogue (LHRH-a) therapy

✍ N.J. Vogelzang; P.F. Schellhammer; R. Sharifi; N.L. Block; M.S. Soloway; P.M. Ve 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 137 KB

A controlled trial of bicalutamide versu

A controlled trial of bicalutamide versus castration in patients with advanced prostate cancer

✍ Gregory T. Bales; Gerald W. Chodak 📂 Article 📅 1996 🏛 Elsevier Science 🌐 English ⚖ 611 KB